Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Physiological Microfluidic Blood-Brain-Barrier Model for In Vitro Study of Nanoparticle Trafficking and Accumulation.

Advanced healthcare materials·2026
Same author

A physiological microfluidic blood-brain-barrier model for in vitro study of nanoparticle trafficking and accumulation.

bioRxiv : the preprint server for biology·2025
Same author

A vascular-associated fibroblastic cell controls pancreatic islet immunity.

Cell reports·2025
Same author

A Microfluidic Strategy to Capture Antigen-Specific High-Affinity B Cells.

Advanced nanobiomed research·2025
Same author

Engineered vasculature induces functional maturation of pluripotent stem cell-derived islet organoids.

Developmental cell·2025
Same author

Vascularized tumor-on-a-chip to investigate immunosuppression of CAR-T cells.

Lab on a chip·2025

Related Experiment Video

Updated: Apr 6, 2026

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

7.7K

Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening.

Yosuke K Kurokawa1, Steven C George2

  • 1Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA.

Advanced Drug Delivery Reviews
|July 28, 2015
PubMed
Summary

Advanced 3D cardiac microphysiological systems using human stem cells offer improved in vitro drug screening for cardiotoxicity. These models better mimic the heart

Keywords:
3D tissueCardiotoxicityIn vitro drug screeningStem cell-derived cardiomyocyte

More Related Videos

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
10:39

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening

Published on: April 15, 2017

13.8K
Capillary Force Lithography for Cardiac Tissue Engineering
10:09

Capillary Force Lithography for Cardiac Tissue Engineering

Published on: June 10, 2014

13.0K

Related Experiment Videos

Last Updated: Apr 6, 2026

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

7.7K
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
10:39

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening

Published on: April 15, 2017

13.8K
Capillary Force Lithography for Cardiac Tissue Engineering
10:09

Capillary Force Lithography for Cardiac Tissue Engineering

Published on: June 10, 2014

13.0K

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Drug Discovery

Background:

  • Accurate detection of drug-induced cardiotoxicity is critical in pharmaceutical development.
  • Human pluripotent stem cell-derived cardiomyocytes are increasingly used for in vitro drug screening.
  • 3D cardiac microphysiological systems are emerging as advanced tools for preclinical safety assessment.

Purpose of the Study:

  • To review progress in developing advanced 3D human heart models.
  • To highlight the role of cellular and extracellular components in cardiac function within these models.
  • To discuss the potential of cardiac microphysiological systems for improved cardiotoxicity detection.

Main Methods:

  • Review of current literature on 3D cardiac microphysiological systems.
  • Analysis of cellular and extracellular matrix contributions to cardiac models.
  • Comparison of model performance with existing preclinical drug screening standards.

Main Results:

  • 3D cardiac microphysiological systems recapitulate native heart microenvironment.
  • These advanced models show potential for more accurate pharmacological responses.
  • Understanding cellular and extracellular components is key to model optimization.

Conclusions:

  • 3D cardiac microphysiological systems represent a significant advancement in cardiotoxicity screening.
  • These models offer a more predictive preclinical assessment of drug safety.
  • Further research into model components will enhance their utility in drug development.